[1]EuropeanJournalofMedicinalChemistry,2017,vol.132,p.26-41
1203260-55-2
1001401-60-0
1159826-44-4
1272758-05-0
1215020-90-8
1217696-54-2
3383-66-2 | 2-(1,3-Benzothiazol-2-ylsulfanyl)propanoic acid | AA00BZSO | MFCD00627566
37478-58-3 | Piperazin-1-yl-acetic acid | AA00BZYE | MFCD03119773
3855-78-5 | 2,3,4-Trimethyl-1h-pyrrole | AA00C06T | MFCD18427137
40534-18-7 | N-Methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine | AA00C0CF | MFCD03848700
3868-36-8 | 8-Benzyloxyguanosine | AA00C0J3 | MFCD08062093
354812-41-2 | Moxifloxacin | AA00C0P5 | MFCD09263698
402473-54-5 | 4-Cyano-2-[[2-(4-fluoro-1-naphthalenyl)-1-oxopropyl]amino]Benzenebutanoic acid | AA00C0UD | MFCD13184814
361-92-2 | 2-(2-Fluorophenyl)benzoic acid | AA00C0XQ | MFCD05022492
303152-93-4 | 2-(1-[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]-1h-indol-3-yl)acetonitrile | AA00C154 | MFCD00664465
3061-95-8 | H-D-Ala-phe-oh | AA00C1DD | MFCD00066030